Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
PROMOTED
Start date:
Apr 08, 2024
End date:
Apr 08, 2024
At14:30 CET (08:30 EST) on Monday 8 April, in Room 2 at EHRA 2024 in Berlin, DE, Radcliffe Education is hosting a CME-accredited symposium entitled 'Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice’.Under the expert moderation ofDr Hugh Calkins (Baltimore, US) and Prof Riyaz Kaba (London, UK) a leading international faculty comprising Prof…
View more
Author(s):
Niels Ramsing Holm
,
Evald Høj Christiansen
Added:
3 years ago
Optimal treatment of left main coronary artery (LMCA) lesions requires a highly tailored approach that incorporates patient comorbidities, clinical presentation, the extent of coronary artery disease (CAD), lesion characteristics and local expertise.1,2 Coronary artery bypass grafting (CABG) is the treatment for LMCA lesions that has the highest evidence level in guideline recommendations.2,3…
View more
Author(s):
David Hildick-Smith
Added:
11 months ago
EuroPCR 23 - Join us as we discover the latest findings from a three-year follow-up of the EBC MAIN Trial, as we interview Principal Investigator Dr David Hildick-Smith (Brighton and Sussex University Hospitals, UK) onsite at EuroPCR 23.
The EBC Main Trial aimed to investigate the outcomes of single-stent versus dual-stent bifurcation treatment of distal left main coronary artery lesions. This…
View more
Author(s):
Edward McNulty
Added:
3 years ago
The debate over the optimal mode of revascularisation for unprotected left main (ULM) coronary artery disease intensified with the advent of drug-eluting stents (DES). Professional society guidelines addressing ULM disease have been revised at an increasing frequency,1,2 the significance of randomised comparisons has been variously interpreted, and observational comparisons have become a…
View more
Author(s):
Adrian P Banning
,
Giovanni Luigi De Maria
Added:
3 years ago
Introduction
Detecting obstructive disease of the left main coronary artery (LMCA) disease is a relatively unusual occurrence in the catheterisation laboratory, as it accounts for approximately 4 % of all coronary angiograms, with isolated LMCA disease observed in only 5–10 % of these cases.1 Historically, coronary artery bypass grafting (CABG) represented the treatment of choice with a well…
View more
Author(s):
Refai Showkathali
,
Radha Priya Yalamanchi
Added:
10 months ago
Author(s):
Rajiv Rampat
,
David Hildick-Smith
Added:
3 years ago
Left main stem (LMS) disease is identified in up to 5 % of diagnostic angiography cases.1 It has major prognostic significance due to the proportion of myocardium at risk. Many years ago, the Coronary Artery Surgery Study (CASS) registry demonstrated the superiority of coronary artery bypass grafting (CABG) over medical therapy with a 5-year mortality reduction from 43 % to 16 % in symptomatic…
View more
Author(s):
Giovanni Luigi De Maria
,
Adrian P Banning
Added:
3 years ago
Detection of obstructive disease of the left main coronary artery (LMCA) is relatively unusual in the catheterisation laboratory, as it accounts for approximately 4 % of all coronary angiograms, with isolated LMCA disease observed in only 5–10 % of these cases.1
Intervention to the LMCA is, however, notable compared to the treatment of coronary stenosis elsewhere in the coronary tree. First,…
View more
Author(s):
Gabriel Torres-Ruiz
,
Nuria Mallofré-Vila
,
Paola Rojas-Flores
,
et al
Added:
4 months ago